Zura Bio ZURA
NASDAQ ZURA
$4.09 -0.04 (-0.85%)
As of: Oct 22, 2026 · 12:56 PM EDT

Zura Bio (ZURA) Notes Payables (2022)

Updated

Zura Bio (ZURA) recorded Notes Payables of $7.76 million in Q4 2022.

Analysis

Zura Bio (ZURA) Notes Payables (2022) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,171.37 Bn 1,139.96 Bn 19.71 Bn
2 Johnson & Johnson 645.23 Bn 565.09 Bn 17.30 Bn
3 AbbVie 502.25 Bn 475.37 Bn 12.70 Bn
4 Merck 361.34 Bn 315.71 Bn 12.21 Bn
5 Novartis Ag 302.82 Bn 266.81 Bn 11.24 Bn
6 Astrazeneca 267.91 Bn 241.60 Bn 12.86 Bn
7 Amgen 242.39 Bn 197.79 Bn 7.24 Bn
8 Gilead Sciences 193.55 Bn 167.74 Bn 6.22 Bn
9 Pfizer 172.05 Bn 118.70 Bn 10.94 Bn
10 Zura Bio 517.99 Mn -161.16 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 7.76 Mn
Sep 30, 2022 299,981.00
Jun 30, 2022 179,006.00
API Access

Zura Bio Notes Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=notes-payables&ticker=ZURA&period=max&api_key=YOUR_API_KEY